Zoetis JV In China Receives Approval For Rui Lan An™ Swine Vaccine Against PRRS

(RTTNews) - Zoetis (ZTS) announced that its joint venture in China received the approval by the Ministry of Agriculture of the People's Republic of China for Rui Lan An, a specialized vaccine to help control the highly pathogenic porcine reproductive and respiratory syndrome or HP PRRS.

The company stated that Rui Lan An is the first vaccine to emerge from the joint venture that was established to develop and manufacture animal vaccines specifically designed to answer the needs of China's livestock producers. It will help China's pork producers meet increasing demand in China for quality, affordable pork, Zoetis noted.

Vaccines for swine have high growth potential as China is the world's leading pork producing nation, with an annual population of more than 685 million pigs in 2012. The joint venture provides a strategic platform for growth in China where the animal health industry is valued at $1.8 billion and is expected to grow at 9.3 percent year over year in the next 5 years, the company said.